Zydus Atenolol 50mg Tablets Recall: Foreign Paroxetine Found
Zydus Pharmaceuticals USA recalls 50mg atenolol tablets that may contain foreign paroxetine tablets. Consumers should check product labels and contact Zydus for details.
Lower-risk recall
Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.
Contact the company
What happened, in plain English
Zydus Pharmaceuticals USA is recalling 50mg atenolol tablets that may contain foreign paroxetine tablets. This could lead to unintended medication interactions if taken without knowing. Read more at govinfonow.com/recall/41857-zydus-atenolol-50mg-tablets-recall-foreign-paroxetine-found.
Source Summary by GovInfoNow · govinfonow.com/recall/41857-zydus-atenolol-50mg-tablets-recall-foreign-paroxetine-found · Updated October 8, 2026 · FDA enforcement record: FDA #D-0605-2017
Cite this page
“Zydus Atenolol 50mg Tablets Recall: Foreign Paroxetine Found.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/41857-zydus-atenolol-50mg-tablets-recall-foreign-paroxetine-found. Based on FDA recall #D-0605-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0605-2017%22&limit=1).
Why it’s dangerous
The recalled tablets may contain paroxetine tablets, a different medication. Taking these could cause unintended interactions with other medications or health conditions.
Who’s affected
People who have the 50mg atenolol tablets from Zydus Pharmaceuticals in 100-count or 1000-count bottles. Those with specific medical conditions requiring atenolol may be at higher risk.
How to tell if you have this one
Check for 100-count or 1000-count bottles labeled 'ATENOLOL Tablets, USP, 50 mg' with NDC 68382-023-01 or 68382-023-10. The lot numbers are Z600724 or Z600725.
- Brand
Zydus Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Label
Look for the product name, NDC codes, and lot numbers on the bottle to confirm if it's recalled.
Contact Zydus
Reach out to Zydus Pharmaceuticals USA for specific instructions on what to do with the product.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA and Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.7 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Zydus Pharmaceuticals recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0605-2017 (March 6, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0605-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.